The majority of patients at one institution who underwent a virtual colonoscopy procedure had extracolonic findings. This could be reason enough for radiologists to be involved in interpreting virtual colonoscopy exams.
The majority of patients at one institution who underwent a virtual colonoscopy procedure had extracolonic findings. This could be reason enough for radiologists to be involved in interpreting virtual colonoscopy exams.
Investigators were surprised by the fact that more than 60% of the 500 patients in the study had extracolonic findings. A relatively large percentage (9%) of those patients had clinically important findings, said lead author Dr. Judy Yee, chief of radiology at the Veterans Affairs Medical Center in San Francisco.
Virtual colonoscopy can safely identify cancers and other diseases outside of the colon - kidney cancers, other masses in solid organs, adenopathy, and aneurysms - that would be missed by conventional colonoscopy, Yee said.
"This study stresses the importance that radiologists interpret this type of study. There is important information outside of the colon that requires specific training to detect," she said.
Yee and colleagues performed virtual colonoscopy in 500 men: 194 had an average risk for colorectal cancer, and 306 were at high risk. The study was published in the August issue of Radiology.
The researchers found that out of 596 extracolonic findings detected, 50 were clinically important. Fourteen of these 50 findings had already been diagnosed before the virtual colonoscopy exams. Of the 35 patients with the 36 remaining findings warranting follow-ups, five underwent surgical treatment for the following:
The mean additional cost for following up important findings was $28.12 per virtual colonoscopy exam, a relatively low amount when weighed against the benefits of the changes made to patient care, according to Yee.
The authors concluded that detection of potentially serious asymptomatic lesions at an early and curable stage can prompt meaningful medical follow-up or surgical intervention, ultimately leading to decreased morbidity and mortality.
Additional studies need to be performed, however, to evaluate the cost-effectiveness to follow up both colonic and extracolonic lesions, Yee said. Additional evaluation of the use of intravenous contrast for the detection of extracolonic findings is also needed.
For more information from the Diagnostic Imaging archives:
CT colonography screening trial seeks definitive answers
Duke study renews challenge of CT colonography
Careful CT colonography technique avoids pitfalls
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.